Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Gland Pheochromocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02592356
What this trial is testing

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more
M.D. Anderson Cancer Center 23
Not applicableStudy completedNCT06064370
What this trial is testing

Side-specific Factors for Intraoperative Hemodynamic Instability in Pheochromocytoma

Who this might be right for
adrenalDisease
Zagazig University 171
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Early research (Phase 1)Not Yet RecruitingNCT07661420
What this trial is testing

211At-MABG in Adults With Advanced Neuroendocrine Cancers

Who this might be right for
PheochromocytomaParagangliomaNeuroendocrine Tumors+3 more
University of Pennsylvania 16
Not applicableStudy completedNCT01022515
What this trial is testing

Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma

Who this might be right for
PheochromocytomaParagangliomaEssential Hypertension
University Hospital, Rouen 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03839498
What this trial is testing

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
Columbia University 6
Not applicableAvailableNCT01590680
What this trial is testing

Expanded Access Protocol Using 131I-MIBG

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Jubilant DraxImage Inc.
Not applicableStudy completedNCT06062082
What this trial is testing

Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma

Who this might be right for
PheochromocytomaNon-Secretory Adrenal Adenoma
Central Hospital, Nancy, France 60
Very early researchActive Not RecruitingNCT03541720
What this trial is testing

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

Who this might be right for
NeuroblastomaPheochromocytoma
St. Jude Children's Research Hospital 13
Not applicableUnknownNCT06050057
What this trial is testing

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Who this might be right for
Adrenal TumorAdrenal DiseaseAdrenal Mass+10 more
University Hospital Olomouc 100
Not applicableStudy completedNCT01425710
What this trial is testing

Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma

Who this might be right for
Pheochromocytoma
Medical University of Vienna 15
Testing effectiveness (Phase 2)UnknownNCT05885386
What this trial is testing

A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL

Who this might be right for
PheochromocytomaParaganglioma
Peking Union Medical College Hospital 20
Not applicableUnknownNCT05752773
What this trial is testing

Prediction of Myocardial Injury After Laparoscopic Pheochromocytoma/ParaGangLioma Resection

Who this might be right for
PGL
Peking Union Medical College Hospital 700
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableActive Not RecruitingNCT05446779
What this trial is testing

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

Who this might be right for
Primary AldosteronismAdrenal Cushing SyndromePheochromocytoma+1 more
Helsinki University Central Hospital 400
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Post-approval studies (Phase 4)Looking for participantsNCT05702944
What this trial is testing

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

Who this might be right for
PheochromocytomaParagangliomaAdrenalectomy; Status+1 more
Seoul National University Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Next Page